These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37850980)

  • 21. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.
    Palummieri A; De Carli G; Rosenthal É; Cacoub P; Mussini C; Puro V;
    BMC Infect Dis; 2017 Nov; 17(1):734. PubMed ID: 29179700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of pre-exposure and post-exposure prophylaxes prevention programme on HIV burden and services in a low-resource setting: a simulation modelling approach.
    Adeoti AO; Demir E; Adeyemi S; Yakutcan U; Kengne AP; Kayode G; Aliyu A; Idika N; Isichei C
    Pan Afr Med J; 2021; 40():163. PubMed ID: 34970405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
    Mansoor LE; Lewis L; Naicker CL; Harkoo I; Dawood H; Naidoo K; Gengiah TN; Samsunder N; Beesham I; Abdool Karim SS; Abdool Karim Q
    J Int AIDS Soc; 2022 Jul; 25(7):e25957. PubMed ID: 35785472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [PrEP for HIV prevention, major tool of the global diversified prevention strategy].
    Slama L
    Rev Prat; 2021 Nov; 71(9):957-959. PubMed ID: 35147307
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
    Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
    J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in HIV post-exposure prophylaxis following sexual exposure in Brazil (2011-2019).
    Crepalde-Ribeiro K; de Oliveira Costa J; Pearson SA; Silveira MR; Mendes JC; Dos Santos SF; Cruz MA; Braga MDG
    AIDS Behav; 2022 Dec; 26(12):4115-4125. PubMed ID: 35841464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing HIV infection: pre-exposure and postexposure prophylaxis.
    Doblecki-Lewis S; Kolber MA
    IUBMB Life; 2014 Jul; 66(7):453-61. PubMed ID: 24975125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV postexposure prophylaxis-in-pocket.
    Billick M; Bogoch II
    CMAJ; 2024 Jul; 196(24):E826. PubMed ID: 38955414
    [No Abstract]   [Full Text] [Related]  

  • 32. Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault.
    Bamberger JD; Waldo CR; Gerberding JL; Katz MH
    Am J Med; 1999 Mar; 106(3):323-6. PubMed ID: 10190382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacoprevention of Human Immunodeficiency Virus Infection.
    Yingling C; Broholm C; Stephenson S
    Nurs Clin North Am; 2020 Sep; 55(3):429-444. PubMed ID: 32762861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada.
    Greenwald ZR; Maheu-Giroux M; Szabo J; Robin JAB; Boissonnault M; Nguyen VK; Thomas R
    BMJ Open; 2019 Jun; 9(6):e028768. PubMed ID: 31248931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Canadian guideline provides evidence-based approach to non-occupational HIV prophylaxis.
    O'Donnell S; Tan DHS; Hull MW
    CJEM; 2019 Jan; 21(1):21-25. PubMed ID: 30457087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure.
    Fisher M; Benn P; Evans B; Pozniak A; Jones M; Maclean S; Davidson O; Summerside J; Hawkins D;
    Int J STD AIDS; 2006 Feb; 17(2):81-92. PubMed ID: 16464267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High HIV risk and syndemic burden regardless of referral source among MSM screening for a PrEP demonstration project in Toronto, Canada.
    Wilton J; Noor SW; Schnubb A; Lawless J; Hart TA; Grennan T; Fowler S; Maxwell J; Tan DHS
    BMC Public Health; 2018 Feb; 18(1):292. PubMed ID: 29486737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral pre-exposure prophylaxis for HIV prevention is highly effective in community settings.
    Bazzi AR
    Evid Based Med; 2016 Jun; 21(3):99. PubMed ID: 27029888
    [No Abstract]   [Full Text] [Related]  

  • 39. Public Health Detailing to Promote HIV Pre- and Postexposure Prophylaxis Among Women's Healthcare Providers in New York City.
    Wahnich A; Gandhi AD; Cleghorn E; Estacio K; Blackstock OJ; Myers JE; Abraham B; Edelstein ZR
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S98-S107. PubMed ID: 34686296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key data from AIDS 2022.
    Owen R; Maan I; Waters L
    HIV Med; 2023 May; 24(5):515-520. PubMed ID: 36349523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.